COVID-19 and SARS are both deadly – but different. SARS symptoms were quick to appear, making it easier to contain. Because health officials were able to contain it, the virus died off.
This week we’ve been looking at the factors in play when considering to ease lockdowns, how the massive costs can be met, and the ongoing search for treatments.
These strategies for easing needle pain and fear make vaccinations and other injections easier for parents and children. They are simple and helpful for all ages, from infants to adults.
They’re conducting research, accommodating testing facilities and turning dorms into quarters for medical professionals while also helping people muddle through hard ethical decisions.
In the search for a rapid COVID-19 vaccine, researchers are modifying a method using the chemical riboflavin now used to prevent disease transmission during blood transfusions.
Karl Schmedders, International Institute for Management Development (IMD); Jung Park, International Institute for Management Development (IMD), and Robert Earle, University of Zurich
Starting to feel a little more optimistic? Look away now.
More countries on the African continent must urgently get involved in clinical trials so that the data collected will accurately represent the continent at a genetic level.
The SARS-CoV-2 virus that causes COVID-19 is constantly mutating. What do these mutations reveal about this virus’s evolution? And will this knowledge help us to develop a long-lasting vaccine?
The new coronavirus, SARS-CoV-2, spreads faster than the H1N1 influenza virus and is much deadlier. SARS-CoV-2 is particularly skilled at keeping cells from calling out for help.
Traditional vaccines can take years to create. Rather than immunizing people with viral proteins, the new approach gives the molecular instructions that allows the body to make its own vaccine.
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand